We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quick Detection of Immune Analytes

By Biotechdaily staff writers
Posted on 01 Sep 2005
A new analysis method permits the simultaneous quantification in body fluids of numerous parameters in the immune system, satisfying the growing demand for more-efficient analysis systems at favorable costs.

The method is based on flow cytometry technology and a new product called FlowCytomix, which permits simultaneous detection of up to 10 analytes by the automatic sorting of fluorescence-labeled cells. More...
Individual cells are detected and differentiated on the basis of their size and fluorescence intensity. FlowCytomix, however, does not measure cells. It assesses the synthetic, fluorescent microspheres that have been coated with specific antibodies and added to the sample.

The microspheres bind substances in body fluids, which can then be identified. Each of the maximum 10 types of microspheres only carries antibodies for a single specific substance. After the separation of microspheres, the bound antibodies can be detected by a specific antibody or two-step reaction. The automatic analysis of the substance size and dye intensity thus allow for the identification and quantification of the bound substance.
The detection sensitivity and results are comparable with classic enzyme-linked immunosorbent assays (ELISAs).

"One of its uses is the measurement of multiple cytokines, which determines an individual's immune status. Cardiovascular marker proteins can also be measured efficiently, and the risk of cardiovascular disease can thus be estimated,” stated Dr. Irene Rech-Weichselbraun, vice president, R&D, Bender MedSystems GmbH (Vienna, Austria). Bender MedSystems developed the FlowCytomix.




Related Links:
Bender MedSystems

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Automatic CLIA Analyzer
Shine i6000
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.